US Patent Issued to Krystal Biotech on July 22 for "Viral vectors for cancer therapy" (Pennsylvania, California Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,775, issued on July 22, was assigned to Krystal Biotech Inc. (Pittsburgh).

"Viral vectors for cancer therapy" was invented by Suma Krishnan (Pittsburgh), Trevor Parry (San Diego), Dana Michelle Previte (Sewickley, Pa.) and Mary Jane Duermeyer (Glenshaw, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding an immunomodulatory polypeptide (e.g., a pro-inflammatory cytokine such as a human IL-2 or IL-12 polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses...